Potassium Chloride Tablet, E · 23 active FDA presentation rows for this drug
Brand: POTASSIUM CHLORIDE
FDA lists Potassium Chloride Tablet, E as To Be Discontinued (Teva Pharmaceuticals USA, Inc.).
No availability text on this FDA row.
Potassium Chloride Tablet, Extended Release: To Be Discontinued
FDA availability text is not recorded on this row. 23 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Potassium Chloride Tablet, Extended Release
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Dosage Form
- Tablet
- Presentation
- Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-05)
- Package NDC
- 62037-720-05
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Nov 21, 2025
- Last Updated
- Nov 21, 2025
- Therapeutic Category
- Endocrinology/Metabolism, Gastroenterology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
Full Drug Profile
potassium chloride
Side effects, interactions, warnings & more
Nearby, Other Potassium Shortage Records
Potassium Chloride Tablet, Extended Release
Teva Pharmaceuticals USA, Inc.
Tablet
Potassium Chloride Tablet, Extended Release
Teva Pharmaceuticals USA, Inc.
Tablet
Potassium Chloride Tablet, Extended Release
Teva Pharmaceuticals USA, Inc.
Tablet
Potassium Chloride Tablet, Extended Release
Upsher-Smith Laboratories, LLC
Tablet
Potassium Chloride Tablet, Extended Release
Upsher-Smith Laboratories, LLC
Tablet
Potassium Chloride Tablet, Extended Release
Upsher-Smith Laboratories, LLC
Tablet
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.